Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 6 February 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Although net sales were broadly in line with the forecast, each profit figure exceeded the previous forecast, mainly because research and development expenses were lower than expected and foreign exchange gains increased as the yen's depreciation continued.
| Item | Details |
|---|---|
| Net Sales | ¥36,400 million → ¥36,645 million（+0.7%） |
| Operating profit | ¥-1,100 million → ¥-660 million |
| Ordinary income | ¥1,050 million → ¥1,679 million（+60.0%） |
| Profit attributable to owners of the parent | ¥900 million → ¥1,473 million（+63.7%） |
| Net income per share | 16.48 yen and sen → 26.99 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 6 February 2026 |
| Previous-period results | Net sales: ¥39,374 million; operating income: ¥1,333 million; ordinary income: ¥1,933 million; net income attributable to owners of the parent: ¥1,214 million; net income per share: ¥22.25 (fiscal year ended March 2025) |
| Reason for the revision | Although net sales were broadly in line with the forecast, each profit figure exceeded the previous forecast, mainly because research and development expenses were lower than expected and foreign exchange gains increased as the yen's depreciation continued. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Each profit figure exceeded the previous forecast because research and development expenses were lower than expected and foreign exchange gains increased as the yen's depreciation continued.